Skip to content
SC
Company

Updated:

SUNOVION CNS DEVELOPMENT CANADA ULC

SUNOVION CNS DEVELOPMENT CANADA ULC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001532079, and its...

Overview

SUNOVION CNS DEVELOPMENT CANADA ULC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001532079, and its reported industry is Pharmaceutical Preparations. The retained history contains 12 filings, including 8-K filed on 2016-10-24. Each filing retains its accession, filing date and original SEC document link. This historical evidence does not establish current registration, listing, ownership or financial condition.

Company overview

Legal name
SUNOVION CNS DEVELOPMENT CANADA ULC
Former names in filing history
Cynapsus Therapeutics Inc. (2011-10-13 to 2016-10-21)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Toronto, Canada
Fiscal year end
December 31
SEC CIK
0001532079

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
8-K8-K
8-K8-K
8-K8-K
8-KFORM 8-K
8-KFORM 8-K
8-K8-K
8-K8-K
SC 13D—SC 13D
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research SUNOVION CNS DEVELOPMENT CANADA ULC in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

SUNOVION CNS DEVELOPMENT CANADA ULC | Company | Altss